- Equifax Inc's EFX price target has been lowered to $300 (an upside of 26%) from $330 by Barclays analyst Manav Patnaik.
- The analyst maintained his Overweight rating on EFX's shares.
- Patnaik's price target reduction mirrors market de-rating and the recession risk.
- Meanwhile, the analyst appreciates the diversity of the company's solution sets and tech-powered innovation capabilities.
- Yesterday, Morgan Stanley lowered its price target on Equifax to $274 (an upside of 16%) from $296 while maintaining the Overweight rating on the shares.
- Also Read: Equifax, Team Velocity Partner On Marketing Solutions For Auto Dealers
- Price Action: EFX shares traded higher by 1.80% at $238.03 on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
